STLN

Starling Oncology Inc.

STLN | NASDAQ
Chart Builder DCF Calculator
$6.53
-$0.12 (-1.80%)
At close: Oct 30, 2026, 3:59 PM ET
$6.61
+$0.08 (+1.27%)
Pre-market: Nov 2, 2026, 9:26 AM ET

Market Data

Market Cap
$652.39M
Enterprise Value
$715.77M
Beta
0.42
Average Volume
1.5M
Shares Outstanding (Diluted)
103.03M
Shares Change YoY
N/A
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US68236X1000

Price Performance

Price Change 1M
3.3%
Price Change 3M
N/A
Price Change 6M
N/A
Price Change YTD
N/A
Price Change 1Y
N/A
Price Change 3Y
N/A
Price Change 5Y
N/A
1M CAGR (ann.)
-6.2%
1Y CAGR (ann.)
N/A
5Y CAGR (ann.)
N/A
All-Time CAGR
45.7%

Valuation

PE Ratio
-21.77
Forward PE
N/A
PEG Ratio
0.32
Forward PEG
0.30
PS Ratio
1.11
Forward PS
0.70
PB Ratio
-26.19
P/FCF Ratio
-198.54
P/Adj. FCF Ratio
-77.82
P/OCF Ratio
N/A
EV/Sales
1.22
EV/EBIT
-24.97
EV/EBITDA
-32.75
EV/FCF
-217.82
Earnings Yield
-4.6%
FCF Yield
-0.5%
Adj. FCF Yield
-1.3%

Financial Health

Net Debt
$38.77M
Total Debt
$104.48M
Cash & Short-Term Investments
$41.09M
Total Assets
$178.23M
Current Ratio
1.36
Quick Ratio
1.15
Debt / Equity Ratio
-4.19
Debt / EBITDA
-4.78
Debt / FCF
-31.79
OCF / Debt
0.00
Interest Coverage
-3.42
Altman Z-Score
2.69
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
15.7%
Operating Profit Margin
-4.4%
EBITDA Margin
-3.7%
Net Profit Margin
-6.2%
FCF Margin
-0.6%
Adj. FCF Margin
-1.4%
SBC / Revenue
0.9%
SBC Impact (per share)
-155.1%

Returns

Return on Assets
-20.4%
Return on Equity
209.8%
Return on Invested Capital
-28.8%
Return on Capital Employed
-31.3%
Return on Tangible Assets
-22.5%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
3
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Aug 6, 2026
EPS Estimate (next Q)
-$0.06
EPS Growth Est (next Q)
-57.3%
Revenue Est (next Q)
$155.74M
Revenue Growth Est (next Q)
30.0%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$9.00
Price Target Upside
37.8%

Cash Flow

Operating Cash Flow
$328K
Free Cash Flow
$-3.29M
Adj. Free Cash Flow
$-8.38M
FCF Per Share
-$0.03
OCF Per Share
$0.00
OCF/S Ratio
0.1%

Income Statement

Revenue
$587.24M
Gross Profit
$92.17M
Operating Income
$-26.09M
EBITDA
$-21.86M
Net Income
$-36.29M
EPS (Diluted)
-$0.30
Revenue / Employee
$916.14K
Profit / Employee
$-56.62K
Employees
641

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.